ID

38710

Beschreibung

Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01475734

Link

https://clinicaltrials.gov/show/NCT01475734

Stichworte

  1. 30.10.19 30.10.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

30. Oktober 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes Mellitus, Type 2 NCT01475734

Eligibility Diabetes Mellitus, Type 2 NCT01475734

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
historical diagnosis of type 2 diabetes mellitus for at least 6 months and less than 10 years before screening
Beschreibung

Non-Insulin-Dependent Diabetes Mellitus Disease length

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
hba1c <10% at screening for subjects who do not require washout of existing oad or <9% at screening for subjects who do require washout from existing oad
Beschreibung

Hemoglobin A1c measurement | Absence Washout Antidiabetics Oral | Washout Antidiabetics Oral

Datentyp

boolean

Alias
UMLS CUI [1]
C0474680
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C1710661
UMLS CUI [2,3]
C0935929
UMLS CUI [2,4]
C1527415
UMLS CUI [3,1]
C1710661
UMLS CUI [3,2]
C0935929
UMLS CUI [3,3]
C1527415
body mass index in range 28 kg/m2 to40 kg/m2
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of pancreatitis or current ongoing symptomatic biliary disease or pancreatitis
Beschreibung

History of pancreatitis | Gall Bladder Disease Symptomatic | Pancreatitis Symptomatic

Datentyp

boolean

Alias
UMLS CUI [1]
C3887021
UMLS CUI [2,1]
C0016977
UMLS CUI [2,2]
C0231220
UMLS CUI [3,1]
C0030305
UMLS CUI [3,2]
C0231220
history of significant gastrointestinal surgery,
Beschreibung

Gastrointestinal Surgical Procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C0524722
history of significant cardiovascular disease
Beschreibung

Cardiovascular Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0007222
history of a seizure disorder
Beschreibung

Epilepsy

Datentyp

boolean

Alias
UMLS CUI [1]
C0014544
documented hypertension or hypotension
Beschreibung

Hypertensive disease | Hypotension

Datentyp

boolean

Alias
UMLS CUI [1]
C0020538
UMLS CUI [2]
C0020649
use of oral antidiabetic agents, except for metformin, within 14 days before investigational product administration.
Beschreibung

Antidiabetics Oral | Exception Metformin

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0025598
current hepatic disease or abnormal liver function tests
Beschreibung

Liver disease | Liver function tests abnormal finding

Datentyp

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0151766
positive test result for hepatitis b, hepatitis c, or human immunodeficiency virus infection 1 or 2
Beschreibung

Hepatitis B test positive | Hepatitis C test positive | HIV-1 test positive | HIV-2 test positive

Datentyp

boolean

Alias
UMLS CUI [1]
C1608966
UMLS CUI [2]
C1609517
UMLS CUI [3]
C1328593
UMLS CUI [4]
C1168371
history of regular alcohol consumption (exceeding 7 drinks/week for women or 14 drinks/week for men)
Beschreibung

Alcohol consumption Regular | Alcoholic drinks per week | Gender

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0001948
UMLS CUI [1,2]
C0205272
UMLS CUI [2,1]
C0001967
UMLS CUI [2,2]
C0332174
UMLS CUI [3]
C0079399
female subject is pregnant (confirmed by laboratory testing), lactating, or less than 6 weeks postpartum
Beschreibung

Pregnancy | Breast Feeding | Postpartum Period

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0086839
known allergy to any glp-1 analog or excipients of albiglutide, baker's yeast, or insulin
Beschreibung

Hypersensitivity GLP-1 Analogue | Hypersensitivity Albiglutide Excipient | Hypersensitivity Saccharomyces cerevisiae | Insulin allergy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3273809
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C2607479
UMLS CUI [2,3]
C0015237
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0036025
UMLS CUI [4]
C0571622
history of type 1 diabetes,
Beschreibung

Diabetes Mellitus, Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011854
prior exposure to glp-1 agents, including albiglutide
Beschreibung

Exposure to GLP-1 Receptor Agonist | Exposure to Albiglutide

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C2917359
UMLS CUI [2,1]
C0332157
UMLS CUI [2,2]
C2607479
blood donation over 500 ml within 8 weeks before screening
Beschreibung

Blood Donation Amount Timespan

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005794
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0872291

Ähnliche Modelle

Eligibility Diabetes Mellitus, Type 2 NCT01475734

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
historical diagnosis of type 2 diabetes mellitus for at least 6 months and less than 10 years before screening
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Hemoglobin A1c measurement | Absence Washout Antidiabetics Oral | Washout Antidiabetics Oral
Item
hba1c <10% at screening for subjects who do not require washout of existing oad or <9% at screening for subjects who do require washout from existing oad
boolean
C0474680 (UMLS CUI [1])
C0332197 (UMLS CUI [2,1])
C1710661 (UMLS CUI [2,2])
C0935929 (UMLS CUI [2,3])
C1527415 (UMLS CUI [2,4])
C1710661 (UMLS CUI [3,1])
C0935929 (UMLS CUI [3,2])
C1527415 (UMLS CUI [3,3])
Body mass index
Item
body mass index in range 28 kg/m2 to40 kg/m2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
History of pancreatitis | Gall Bladder Disease Symptomatic | Pancreatitis Symptomatic
Item
history of pancreatitis or current ongoing symptomatic biliary disease or pancreatitis
boolean
C3887021 (UMLS CUI [1])
C0016977 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C0030305 (UMLS CUI [3,1])
C0231220 (UMLS CUI [3,2])
Gastrointestinal Surgical Procedure
Item
history of significant gastrointestinal surgery,
boolean
C0524722 (UMLS CUI [1])
Cardiovascular Disease
Item
history of significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Epilepsy
Item
history of a seizure disorder
boolean
C0014544 (UMLS CUI [1])
Hypertensive disease | Hypotension
Item
documented hypertension or hypotension
boolean
C0020538 (UMLS CUI [1])
C0020649 (UMLS CUI [2])
Antidiabetics Oral | Exception Metformin
Item
use of oral antidiabetic agents, except for metformin, within 14 days before investigational product administration.
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
Liver disease | Liver function tests abnormal finding
Item
current hepatic disease or abnormal liver function tests
boolean
C0023895 (UMLS CUI [1])
C0151766 (UMLS CUI [2])
Hepatitis B test positive | Hepatitis C test positive | HIV-1 test positive | HIV-2 test positive
Item
positive test result for hepatitis b, hepatitis c, or human immunodeficiency virus infection 1 or 2
boolean
C1608966 (UMLS CUI [1])
C1609517 (UMLS CUI [2])
C1328593 (UMLS CUI [3])
C1168371 (UMLS CUI [4])
Alcohol consumption Regular | Alcoholic drinks per week | Gender
Item
history of regular alcohol consumption (exceeding 7 drinks/week for women or 14 drinks/week for men)
boolean
C0001948 (UMLS CUI [1,1])
C0205272 (UMLS CUI [1,2])
C0001967 (UMLS CUI [2,1])
C0332174 (UMLS CUI [2,2])
C0079399 (UMLS CUI [3])
Pregnancy | Breast Feeding | Postpartum Period
Item
female subject is pregnant (confirmed by laboratory testing), lactating, or less than 6 weeks postpartum
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0086839 (UMLS CUI [3])
Hypersensitivity GLP-1 Analogue | Hypersensitivity Albiglutide Excipient | Hypersensitivity Saccharomyces cerevisiae | Insulin allergy
Item
known allergy to any glp-1 analog or excipients of albiglutide, baker's yeast, or insulin
boolean
C0020517 (UMLS CUI [1,1])
C3273809 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C2607479 (UMLS CUI [2,2])
C0015237 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0036025 (UMLS CUI [3,2])
C0571622 (UMLS CUI [4])
Diabetes Mellitus, Insulin-Dependent
Item
history of type 1 diabetes,
boolean
C0011854 (UMLS CUI [1])
Exposure to GLP-1 Receptor Agonist | Exposure to Albiglutide
Item
prior exposure to glp-1 agents, including albiglutide
boolean
C0332157 (UMLS CUI [1,1])
C2917359 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C2607479 (UMLS CUI [2,2])
Blood Donation Amount Timespan
Item
blood donation over 500 ml within 8 weeks before screening
boolean
C0005794 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0872291 (UMLS CUI [1,3])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video